Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.

Neehar D ParikhNeil MehtaMaarouf A HoteitJu Dong Yang Binu V JohnAndrew M MoonReena J SalgiaAnjana PillaiIhab KassabNaba SaeedEmil ThyssenPiyush NathaniJeffrey McKinneyWesley ChanClaire DurkinMatthew ConnorManaf AlsudaneyRajesh KonjetiBrenda DurandNicholas N NissenHannah P KimRaghavendra PaknikarNicole E RichMatthew J SchipperAmit G Singal

Published in: Cancer (2022)

Patients with HCV-related HCC and SVR are less likely to experience hepatic decompensation than viremic patients, suggesting patients with HCC who are undergoing nonsurgical therapies may benefit from DAA treatment.

Keyphrases

end stage renal disease
ejection fraction
hepatitis c virus
prognostic factors
hiv infected
combination therapy
human immunodeficiency virus
hiv infected patients
replacement therapy